在新辅助化疗后,NOXA表达在人类乳腺癌中受到下调,经历不完全的病理反应和衰老
Sofian Al Shboul1, Mohammed El-Sadoni2, Ahmad Alhesa2
1Department of Pharmacology and Public Health, Faculty of Medicine, The Hashemite University, Zarqa, 13133, Jordan.
Scientific reports
|September 23, 2023
概括
新辅助化疗 (NAC) 可能导致乳腺癌患者NOXA表达减少和治疗诱导衰老 (TIS) 增加,这些患者无法达到完全的病理反应,这表明这些因素会影响治疗结果.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 新辅助化疗 (NAC) 是局部晚期乳腺癌的标准.
- 瘤对NAC的反应有所不同,有些瘤无法达到完全的病理反应.
- 亡和治疗诱导衰老 (TIS) 在NAC反应中的作用尚未完全理解.
研究的目的:
- 在NAC之后,调查NOXA表达和TIS标记物的变化.
- 为了将这些变化与乳腺癌中NAC的病理反应相关联.
主要方法:
- 在两个乳腺癌数据集中分析了PAMIP1 (NOXA基因) 表达.
- 在NAC前后55名患者样本中测量NOXA蛋白水平.
- 在NOXA下调的样本中评估了TIS标记物 (Lamin-B1,Ki-67,p16INK4a).
主要成果:
- 在两个数据集中,PAMIP1表达在NAC后下降.
- 75%的患者样本在NAC后显示NOXA下调.
- 患有NOXA下降的患者经常表现出TIS标志物:拉敏B1减少 (66%),Ki-67减少 (80%),p16INK4a增加 (49%).
结论:
- 在乳腺癌中观察到NOXA的降低调节和TIS的诱导,而对NAC的反应低于最佳.
- 这些发现表明NOXA下调和TIS可能会导致对NAC的耐药性.
- 需要进一步的研究来探索针对这些机制的治疗策略.
更多相关视频
09:08Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
Published on: January 12, 2020
6.8K
08:48An In Vitro Dormancy Model of Estrogen-sensitive Breast Cancer in the Bone Marrow: A Tool for Molecular Mechanism Studies and Hypothesis Generation
Published on: June 30, 2015
8.3K
相关概念视频
Receptor Downregulation in MVBs
2.1K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.1K
The Nucleolus
8.9K
The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
8.9K
Loss of Tumor Suppressor Gene Functions
4.9K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
4.9K
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
